Cardiovascular Disease Epidemiology Training Program
Established in 1975, the Cardiovascular Disease Epidemiology Training Program focuses on interdisciplinary training on the epidemiology of the leading cause of death in the United States. The program integrates knowledge on all aspects of cardiovascular disease: biology, behavior, treatment and prevention. Training emphasizes active participation in research and translational epidemiology using a collaborative approach, which is enhanced by the close relationships between the Department of Epidemiology and the clinical departments of the Johns Hopkins School of Medicine at the Johns Hopkins Hospital. A number of large ongoing cohort studies and clinical trials provide a rich environment for the conduct of research. The main didactic course focuses on risk factors for cardiovascular disease and strategies for prevention. Seminar-style courses offer a more in-depth understanding of disease pathophysiology and clinical management.
The strengths of the program include the existing depth of interest and expertise in cardiovascular disease epidemiology at the Johns Hopkins Medical Institutions, as well as the enthusiasm, commitment, and experience in training and mentorship of the Program Director (Dr. Josef Coresh), Program Co-director (Dr. Elizabeth Selvin) and program faculty. Many trainees are based in the Welch Center for Prevention, Epidemiology and Clinical Research and are mentored by individuals active in both population-based and clinical research. Among other outstanding collaborations, the program benefits from close ties with the Johns Hopkins University divisions of General Internal Medicine, Cardiology and Endocrinology.
Tuition and stipend funding for doctoral candidates and post-doctoral trainees (Masters after MD, or another degree or research after a PhD) is available on a merit basis through an NIH training program for US citizens or permanent residents.
Publications of the Cardiovascular Disease Epidemiology Training Program
Training grant support should be acknowledged whenever appropriate (papers, presentations, CV). The recommended text for papers is: Dr. Smith was supported by National Heart, Lung, and Blood Institute grant T32HL007024, or this study was supported by grant T32HL007024